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Abstract 112 
Primary open-angle glaucoma (POAG), the most common optic neuropathy, is a highly heritable 113 
disease. Intraocular pressure (IOP) and optic nerve head characteristics are used clinically to predict 114 
POAG risk. We conducted a genome-wide association meta-analysis of IOP and optic disc parameters 115 
and validated our findings in POAG cases. .   found that pathways involved are not entirely distinct as 116 
assumed. Further, we identified a novel association between CDKN1A and POAG. Using a zebrafish 117 
model we show that six6b (associated with POAG and optic nerve head variation) alters the 118 
expression of cdkn1a.  119 
 120 
 121 
 122 
 123 
 124 
 125 
Introduction 126 
In primary open-angle glaucoma (POAG), loss of retinal ganglion cells and nerve fibers manifests itself 127 
clinically as optic nerve damage, which leads to visual field loss and, eventually, blindness(1-3). The 128 
optic nerve damage is characterized by an increase in cup , the central  of the optic nerve head (or 129 
optic disc). This damage can be quantified by the vertical cup-disc ratio (VCDR), comparing the 130 
vertical diameter of the cup with the vertical diameter of the total optic disc.(4) 131 
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Elevated intraocular pressure (IOP) is a well-recognized risk factor and current POAG therapies lower 132 
IOP by various mechanisms. Sib relative risk analyses suggest that POAG is highly heritable(5)(6) and 133 
several genome-wide association studies (GWAS) have identified new POAG genes by examining 134 
POAG directly or studying endophenotypes like VCDR and IOP(7-16). Several genes associated with 135 
VCDR and IOP - CDKN2B-AS1, SIX6 (VCDR); and CAV1/CAV2, TMCO1, ABCA1 and ARHGEF12 (IOP) - 136 
are highly significantly associated with POAG. Notably, no genes have been significantly (genome-137 
wide) associated with both VCDR and IOP. Charlesworth et al. previously found a genetic correlation 138 
between VCDR and IOP (RhoG = 0.45, P = 0.0012), however, genes underlying this relationship have 139 
not yet been identified(17). 140 
The aims of this study were to (1) identify new genes associated with the POAG endophenotypes IOP, 141 
VCDR, cup area, and disc area, and ultimately POAG, using the 1000 Genomes imputations reference 142 
panel, and (2) investigate the genetic overlap between the different endophenotypes. To accomplish 143 
these aims we performed a meta-analysis of GWAS of these four traits within the International 144 
Glaucoma Genetics Consortium (IGGC). 145 
146 
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Results 147 
Intraocular pressure 148 
After removal of single nucleotide polymorphisms (SNPs) with minor allele frequency (MAF) < 0.01 149 
and low imputation quality, approximately 8 million SNPs were included. Whilst the analysis of 150 
individuals of European descent yielded no novel associations, combined analysis of individuals of 151 
European and Asian descent (n = 37,930, λ = 1.05; Supplementary Material, Figs S1a, S1b and S2b), 152 
yielded nine genomic regions reaching genome-wide significance, of which eight genomic regions 153 
were already known (Supplementary Material, Figs S1a, S1b, S2b, and Table S3)(9, 11, 13). The peak 154 
SNP in the new genomic region was rs55796939 on chromosome 11q25 near ADAMTS8 155 
(Supplementary Material, Figs S3 and S4).(18) 156 
 157 
Vertical cup-disc ratio 158 
In the meta-analysis of individuals of European descent (n = 23,899, λ = 1.08), 21 genomic regions 159 
were genome-wide significant (Supplementary Material, Figs S5a, S6a and Table S4). Five genomic 160 
regions were novel (near to the genes RPE65 on chr. 1p31, F5 on chr. 1q23, PDZD2 on chr. 5p13.3, 161 
RREB1 on chr. 6p25, and DGKB on chr. 7p21.2) (Supplementary Material, Figs S7 and S8); the other 162 
genomic regions have been previously associated with VCDR or cup area, two highly correlated 163 
traits(19-21). Of the five novel genomic regions, RREB1 (p-value = 4.13 x 10-3) was nominally 164 
significant in the analysis of individuals of Asian descent (n= 8,373, λ = 1.01). In the combined analysis 165 
(n = 32,272, λ = 1.06), another four novel genomic regions, near to the genes VCAN on chr. 5q14.3, 166 
PSCA on chr. 8q24.2, ENO4 on chr. 10q25.3, and RBM23 on chr. 14q11.2 (Supplementary Material, 167 
Figs S5b and S6b), were genome-wide significant leading to a total of nine (5+4) novel genomic 168 
regions associated with VCDR. Of these novel genomic regions, F5 has been associated with disc area 169 
previously(21). Disc area influences the VCDR(22), and therefore we corrected VCDR for disc area in a 170 
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secondary analysis. After correction for disc area, the β (p-value) decreased from -0.007 (2.15 x 10-9) 171 
to -0.002 (5.60 x 10-2) in the subset with disc area available, suggesting that F5 acts primarily on disc 172 
area and secondary to VCDR through its relation to disc area. The calculated h2 of VCDR using the 173 
European -only meta-analysis was 0.31. 174 
 175 
Cup area 176 
The meta-analysis of individuals of European descent (n = 22,489, λ = 1.06) yielded 17 genome-wide 177 
significant regions of which 14 regions were already implicated for cup area or VCDR (Supplementary 178 
Material, Figs S9a, S10a and Table S5)(20, 21). There were three novel associations on chr. 1q42.11 179 
near CDC42BPA, chr. 8q21.11 near CRISPLD1, and on chr. 15q26.3 near FAM169B (Figs S11 and S12). 180 
CDC42BPA has previously been associated with disc area and the fact that the association with cup 181 
area adjusting for disc area is genome wide significant suggests an independent effect on cup area. In 182 
the combined analysis of European and Asian individuals (n = 29,828, λ = 1.06, Supplementary 183 
Material, Figs S9b and S10b) all loci except FAM169B and CRISPLD1 remained genome-wide 184 
significant, and there was one additional genome-wide significant SNPs at chr. 6p21.2 (CDKN1A) and 185 
one highly suggestive significant SNP at chr. 9q34.2 (ABO; previously associated to IOP). 186 
Disc area 187 
The meta-analysis of individuals of European descent (n = 22,504, λ = 1.06) resulted in 13 genome-188 
wide significant regions, of which two were not previously associated with disc area: UGT8 on chr. 189 
4q26 and CTNNA3 on chr. 10q22.2 (Supplementary Material, Figs S13a, S14a, S15, S16, and Table 190 
S6). These SNPs were not significant in the meta-analysis of individuals of Asian descent (n = 7,307, λ 191 
= 1.02). An additional four SNPs reached genome-wide significance in the combined meta-analysis (n 192 
= 29,811, λ = 1.07): PRDM16 on chr. 1p36.23-p33, GADD45A on chr. 1p31.2, VGLL4 on chr. 3p25.3, 193 
and ASB7 on chr. 15q26.3 (Supplementary Material, Figs S13b and S14b). 194 
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Characterization of the lead association signals 195 
In total, 82 SNPs were associated with one or more of the above endophenotypes. Functional 196 
characterization of the 82 SNPs was performed using a range of bioinformatics tools (see Methods). 197 
In total, 650 variants in linkage disequilibrium (LD) with the 82 lead SNPs (R2 >0.8) were examined for 198 
functional annotation. Overall, 61% (50/82) of the associated loci are in LD with variants located in 199 
regulatory regions according to the ENCODE data (e.g. DNase I hypersensitive sites, transcription 200 
factor binding sites and motifs; see Supplementary Material, Table S7). We investigated the 201 
expression levels of the identified candidate genes using the UniGene database(23). Of all reviewed 202 
genes, CDKN1A, PAX6 and DUSP1 showed the highest number of transcripts per million in the eye 203 
(Supplementary Material, Table S8). According to the Ocular Tissue database(24), CDKN1A is highly 204 
expressed in the optic nerve head, as well as DUSP1, which also shows high expression in the 205 
trabecular meshwork. Both genes were associated with optic nerve head parameters. PAX6 is highly 206 
expressed in the ciliary body and retina, in this study we found it associated with disc area. Other 207 
highly expressed genes in the optic nerve include EFEMP1 and ABI3BP, which are associated with cup 208 
area and disc area, respectively (Supplementary Material, Table S9). (25) 209 
 210 
Gene-based test 211 
To identify new loci not found through per-SNP tests, we performed gene-based testing using 212 
VEGAS2. Reflecting the smaller number of tests, our gene-based significance threshold is Pgene-based < 213 
0.05/24,769 = 2.02 x 10-6 (24,769 genes tested). Using the gene-based test we found several novel 214 
loci (Supplementary Material, Table S10). C9 was significantly associated with IOP (p-value 1.61 x 10-215 
6); RARB (p-value 1.86 x 10-6) and HORMAD2-AS1 (p-value 1.04 x 10-6) were associated with VCDR. 216 
These genes were previously associated with disc area, so the novel associations with VCDR could 217 
possibly be driven by the influence of disc area on VCDR(21). In the cup area analysis, the genes 218 
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LRP10 (p-value 1.20 x 10-6) and REM2 (p-value 1.55 x 10-6), and THSD4 (p-value 5.44 x 10 8) were 219 
significantly associated. The first two genes are located near to RBM23, which was significant in the 220 
per-SNP test. THSD4 is located near to KPNB1, which was associated with VCDR in our previous meta-221 
analysis(20). In the disc area analysis we found two genes that were significantly associated with disc 222 
area: ANKRA2 (p-value 8.42 x 10-7) and LOC149950 (p-value 3.87 x 10-7). 223 
 224 
Characterizing the overlap in biological pathways involved in glaucoma endophenotypes 225 
In total, 86 SNPs were associated with one or more of the above endophenotypes. The effect 226 
estimates and p-values of these SNPs for all four endophenotypes are shown in Table 1-3. ADAMTS8 227 
(IOP and VCDR, Table 1 and Table2b) and ABO (IOP and cup area, Table 1) were genome-wide 228 
significantly associated with two traits. Of note is that there were different variants involved in 229 
ADAMTS8: rs55796939 for IOP and rs4936099 for VCDR (r2=0.03 between these SNPs in 1000G 230 
European samples). Figure 1 shows the overlap in associations across endophenotypes – we depict 231 
annotated genes for which at least one SNP was genome-wide significant in at least one trait. 232 
Overlap is defined as nominal significance or stronger for the second trait. The figure shows as 233 
expected a strong overlap in variants associated to disc area, cup area and VCDR. Further, overlap is 234 
noted in genes associated to IOP, cup area and VCDR. 235 
To further characterize the overlap in biological functions, gene set enrichment of loci associated 236 
with IOP and optic disc parameters was performed using DEPICT(25). We first investigated enriched 237 
pathways or gene sets using only genome-wide associated SNPs. No significant pathways were found 238 
after FDR correction. However, pathways involved in metabolic processes such as “increased 239 
circulating leptin level”, “abnormal fat cell morphology” and “increased insulin sensitivity” were 240 
suggestive when we analyzed the list of SNPs associated with VCDR, cup area and disc area (FDR<0.2, 241 
see Supplementary Material, Table S11). We next searched for enriched pathways using suggestive 242 
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SNPs (p-value <1.0 x 10-5). We further investigated potential overlap in pathways across the 243 
endophenotypes, and found 57 significant pathways when using VCDR, cup area and IOP variants; 244 
and 100 pathways when analysing suggestive VCDR, cup area and disc area variants. Note that in the 245 
first analysis we investigated pathways enriched when IOP genes are taken into account, while in the 246 
second one we analysed genes influencing the optic nerve head characteristics. Due to a high degree 247 
of redundancy between pathways, we clustered the significant pathways into meta-pathways, 248 
resulting in 11 meta-pathways for VCDR, cup area and IOP (Figure 2a, Supplementary Material, 249 
Table S12); and 17 for VCDR, cup area, and disc area (Figure 2b, Supplementary Material, Table 250 
S13). Most of the gene sets found in both analyses highlighted pathways involved in cell 251 
differentiation, notch signaling, regulatory DNA binding and embryonic development, which reflects 252 
the pathways found when VCDR and CA variants are analyzed (Supplementary Material, Fig S17). 253 
Furthermore, we found “abnormal fat cell morphology” and “abnormal liver morphology” 254 
significantly enriched; a key gene in these pathways is ABCA1. When IOP genes are included the 255 
elongation factor, RNA Polymerase II (ELL2) protein complex” shows an enrichment. When disc area 256 
genes are included, pathways such as “blood vessel development”, “protein import into nucleus”, 257 
“Thrombospondin 1 (THBS1) and SMAD3 protein complex”, and “abnormal eye morphology” were 258 
significant. Key genes in the latter include: CDKN2B, FAT4, LRIG3, SIX6, COL8A1, SOX11, RND3, BOC, 259 
WNT2B and CYP26A1. 260 
 261 
From endophenotypes to primary open-angle glaucoma 262 
 75 independent (i.e. R2 < 0.8) SNPs associated with one or more of the endophenotypes, 32 were 263 
nominal significantly associated with POAG in a meta-analysis of 6,429 cases and 41,404 controls (p-264 
value <0.05; the chance that 32 SNPs of 75 SNPs have a p-value <0.05 is < 2.2 x 10-16), and 11 265 
independent SNPs were Bonferroni significantly associated with POAG (p-value 0.05/75 = 6.67 x 10-4) 266 
(Table 4). Of these, the rs2487048 in the ABCA1 gene and the 11:120357425 in the ARHGEF12 267 
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showed high heterogeneity (I2). To estimate the common effect size we performed a random effect 268 
meta-analysis. The odds ratio (OR) remained almost the same for both variants, although p-values 269 
were not significant after adjusting for multiple testing, which is in line with the heterogeneity 270 
observed. All other nine SNPs surpassed the Bonferroni threshold for significance in both fixed and 271 
random-effect models. The association between CDKN1A and POAG is novel (OR = 1.14, p-value = 7.4 272 
x 10-7). In our previous paper, the SNP rs6054374 near to BMP2 was already associated with POAG 273 
(OR = 0.92, p-value 3.74 x 10-3), but the most significantly associated SNP in the current meta-analysis 274 
rs6107845 near to BMP2 shows a slightly larger effect on POAG (OR = 0.89, p-value = 8.52 x 10-6). 275 
CDKN1A  gene family as CDKN2B,  276 
 277 
Expression of cdkn1a after knockdown of six6b in zebrafish 278 
(26, 27)(27),nockdown of six6b was achieved using morpholino technology(27). 85% of the 279 
knockdown embryos showed a small eye phenotype, reduced optic nerve thickness and an up-280 
regulation of the expression levels of cdkn2a/cdkn2b, as observed in previous studies (n=220)(27, 281 
28). In zebrafish, there is only one gene which is analogous to the human CDKN2A and CDKN2B and it 282 
is referred to in this paper as cdkn2a/cdkn2b. We evaluated the expression levels of cdkn1a in six6b 283 
deficient embryos by RT-qPCR. A 41-fold overexpression of cdkn1a in the eye of six6b knockdown 284 
embryos was found (p-value = 0.001) (Figure 3), showing that in vivo downregulation of six6b affects 285 
the expression levels not only of cdkn2a/cdkn2b but also of cdkn1a, likely by binding to their 286 
sequence, repressing their expression. 287 
 288 
Discussion 289 
This meta-analysis within the IGGC identified a novel genomic region associated with IOP, nine 290 
genomic regions associated with VCDR, five with cup area, and six with disc area. Eleven genomic 291 
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regions were associated with POAG. Of these regions, the association between CDKN1A and POAG is 292 
novel.  293 
We identify some specific loci that underlie the genetic correlation between IOP and VCDR described 294 
earlier(17). ADAMTS8 and ABO were genome-wide significant for both IOP and VCDR or cup area. 295 
Variants found close to ABO (rs8176672 for cup area and rs8176741 for IOP) are in LD (r2 >0.85) with 296 
rs12216891, which lies in an enhancer and promoter histone mark, suggesting a potential regulatory 297 
mechanism in that region. Furthermore, TRIOBP is genome-wide significant for cup area, and reached 298 
a p-value of 3.42 x 10-6 for IOP. Interestingly, TRIOBP is approximately 180 kb away from CARD10 299 
which is associated with disc area. There is a large overlap between VCDR/cup area and disc area. 300 
Since VCDR is related to disc area, it might be that the effect found for VCDR is due to the effect of 301 
disc area. Most of these overlapping genes are still Bonferroni significant in the cup area analysis in 302 
which we corrected for disc area. Only CDC7/TGFBR3 and F5 are genome-wide significant for VCDR as 303 
well as for disc area, but the effect is negligible after correction for disc area, suggesting that these 304 
two genes play primarily a role in disc area. 305 
When suggestive SNPs (p-value <1.0 x 10-5) for VCDR and cup area are analyzed together using 306 
DEPICT, we found an enrichment of pathways involved in cell differentiation, development, 307 
regulatory DNA binding and Notch signaling. Including disc area SNPs to the VCDR and cup area 308 
analysis reveals additional joint pathways: 1) eye and blood vessel development, 2) cancer, 3) protein 309 
import into nucleus, and 4) thrombospondin 1 and SMAD3 complexes, related to the extracellular 310 
matrix. Of interest, known POAG genes also fit in these pathways identified in this paper based on 311 
endophenotypes: GAS7 and SIX6 play a role during development(27, 29), TGFBR3 has been 312 
implicated in extracellular matrix regulation(30) and in cancer as well as GMDS(31).  313 
The extracellular matrix pathway has been previously implicated in optic nerve degeneration(20), 314 
and emerges in the DEPICT analyses. Both ADAMTS8 and COL8A1 have a role in this pathway. The 315 
encoded protein of the novel identified gene VCAN (versican) is also a major component of the 316 
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extracellular matrix. Another member of the ADAMTS family (ADAMTS5) plays a role in the 317 
regulation of versican(32). Interestingly, mutations in VCAN have been implicated in several 318 
ophthalmologic disorders(33). 319 
. The gene CDKN1A, also known as p21, CIP-1 or WAF-1, the same family as CDKN2B and also 320 
encodes a cyclin-dependent kinase inhibitor. Upregulation of CDKN1A causes G1 arrest and inhibits 321 
proliferation of the cell. Herein, for the first time, we provide genome-wide significant evidence for 322 
association of CDKN1A variants with cup area. Two prior small cohort studies suggested a possible 323 
role of CDKN1A in POAG. Tsai et al.(34) found an association between a codon 31 polymorphism in 324 
CDKN1A and POAG in 58 patients and 59 controls from China (OR = 2.39 [1.14-5.01]). Saglar et al. 325 
found no statistically significant association between the codon 31 polymorphism and POAG in 75 326 
patients and 119 controls from Turkey (OR = 1.70, p-value = 0.25)(35). Our study provides strong 327 
evidence for the role of CDKN1A in POAG risk in a large sample consisting of 6,429 cases and 41,404 328 
controls and shows the first convincing evidence for association of CDKN1A and POAG in individuals 329 
of European descent. (26, 27)in vivo studies in embryonic zebrafish eye  that knockdown of six6b 330 
upregulates both cdkn2a/cdkn2b and cdkn1an a recent study, Skowronska-Krawczyk et al. showed 331 
that SIX6 regulates the expression of CDKN2A (26).More comprehensive studies at the individual 332 
tissue level e.g. retinal ganglion cell layer or optic nerve should be performed to 333 
evaluate(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46) 334 
The synthesis of CDKN1A is increased by the binding of p53 to p53-specific DNA consensus 335 
sequence(47, 48). It has been suggested that p53 plays a role in POAG, especially in POAG with 336 
paracentral visual field loss(49).In a p53 knockout mouse model, less apoptosis was observed after 337 
induction of high IOP. Suggesting that the downregulation of p53 could attenuate the cell damage 338 
caused by high IOP levels(26). Other genes also play a role in p53. GADD45A is involved in growth 339 
arrest through p53 dependent and independent mechanisms(47, 50) and can interact via 340 
CDKN1A(51). Other novel identified genes might also play a role in p53-induced apoptosis. It has 341 
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been shown that the secreted pdzd2 protein activates p53 by transcriptional regulation(52). Also 342 
RREB1 has an effect on p53 by binding to its promotor and transactivates its expression(53). This 343 
gene encodes a zinc finger transcription factor. This can bind to the RAS-responsive element of the 344 
calcitonin gene promotor which subsequently increases the expression of calcitonin. Calcitonin may 345 
be involved in the Ras/Raf signaling cascade that plays a role in the morphogenesis of retinal ganglion 346 
cells, the cell type affected by glaucoma, during neurogenesis(54). Also PSCA is probably involved in 347 
p53-related pathways(55). Other genes play a role in apoptosis or cell growth via other pathways 348 
than p53: VGLL4 inhibits Bax- and TNFa-induced apoptosis(56) and DGKB is a regulator of 349 
diacylglycerol, which is important for cell growth and differentiation. UGT8 plays a role in the 350 
biosynthesis of the sphingolipids of myelin membranes of the central and peripheral nervous system; 351 
sphingolipids are also implicated in apoptosis(57). 352 
Another interesting novel gene is RPE65 (retinal pigment epithelium -specific protein 65kDa). This 353 
gene has been associated with retinitis pigmentosa (RP) (58, 59) and Leber congenital amaurosis type 354 
2 (LCA2)(60). As the name implies, the encoded protein is located in the retinal pigment 355 
epithelium(61). It is involved in the conversion of all-trans retinal to 11-cis retinal, which is a 356 
necessary step in the visual cycle. Both diseases (RP and LCA2) are not characterized by an excavation 357 
of the optic nerve head. However, we have checked several online databases for expression in 358 
different tissues. In the eye, it is also highly expressed in the optic nerve head (S8 and S9 Tables) 359 
suggesting that this gene could be involved in other ocular processes. Little expression is found in the 360 
brain, with no expression in other tissues or organs in the body. Future studies are necessary to 361 
confirm our finding. 362 
Of the genes identified by gene-based testing, C9 (complement component 9) is especially 363 
interesting. Its protein is part of the membrane attack complex (MAC), together with the proteins 364 
C5b, C6, C7, and C8. This complex activates several steps that lead to cell death, and cells protect 365 
themselves by removing the complex through endocytosis. Caveolin is one of the proteins involved in 366 
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endocytosis and the CAV1/CAV2 genes are associated with IOP and POAG. It has been shown that 367 
inhibition of caveolin-1 inhibits the endocytosis of MAC(62). 368 
To our best knowledge, this meta-analysis is the largest study of IOP and optic nerve head 369 
parameters to date, using well-characterized datasets from populations world-wide. A limitation of 370 
our study is the lack of an available dataset for replication of the novel associations detected by 371 
combined European and Asian ancestry samples. However, the heterogeneity of these novel genomic 372 
regions is generally low in the meta-analysis. For VCDR, cup area, and disc area we have identified 373 
novel SNPs in the analysis of individuals with European ancestry. Of the nine novel associations found 374 
in these populations (RPE65, PDZD2, RREB1, DGKB for VCDR; CDC42BPA, CRISPLD1 and FAM169B for 375 
cup area; and CTNNA3 and UGT8 for disc area), only RREB1 was nominally significant in the 376 
individuals with Asian ancestry. Five of the seven non-significant SNPs in the individuals with Asian 377 
ancestry had an effect estimate in the same direction. As the analysis in individuals with Asian 378 
ancestry contains a smaller number of individuals, this could be due to lack of power.  379 
We have identified 21 genetic variants associated with POAG endophenotypes. (63)These association 380 
results do not imply that the variants described here have a causal effect. Fine-mapping and 381 
functional studies are required to identify the causal variants tagged by our findings and the exact 382 
molecular mechanisms involved in POAG. In conclusion, we have found novel genomic regions 383 
associated with the POAG endophenotypes: IOP, VCDR, cup area, and disc area. Although the overlap 384 
between IOP-loci and the optic disc parameters-loci is not large , this is the first study showing a 385 
genome-wide significant evidence of the genetic correlation between IOP and VCDR; we expect that 386 
larger sample sizes and improved imputation accuracy may help to find more of the loci underlying 387 
the genetic correlation between these two endophenotypes. Of the novel associations, CDKN1A is 388 
strongly associated with POAG, This finding is in line with other studies(26), pointing to the CDK-389 
inhibitor genes as key players in the development of POAG. The p53 pathway has been implicated in 390 
POAG, intriguingly, p53 has been also related to the CDK-inhibitors and to four of the new genes 391 
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pointed out by this study (GADD45A, PDZD2, RREB1 and PSCA). Functional studies need to be 392 
performed to assess the role of p53 and CDK-inhibitors in the pathophysiology of POAG. A more 393 
comprehensive study of these mechanisms may inform the development of new therapies for POAG. 394 
395 
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Materials and methods 396 
Study design 397 
We performed a meta-analysis on directly genotyped and imputed SNPs to the 1000 Genomes 398 
reference panel. We analyzed four outcomes: IOP, VCDR, cup area, and disc area. In the first stage, 399 
we included 22,489-29,578 individuals with European ancestry. Subsequently, we evaluated the 400 
genome-wide significant SNPs from the first stage in 7,307-8,373 individuals with Asian ancestry. 401 
Finally, we performed a meta-analysis of GWAS summary findings from all individual studies 402 
including individuals with European and Asian ancestry. We subsequently tested the effect of all 403 
genome-wide significant SNPs on POAG in four independent case-control studies(7, 64)(65). 404 
 405 
Subjects, phenotyping and genotyping 406 
All 19 studies included in this meta-analysis are part of the IGGC (S1a Table).Details for each 407 
individual study can be found in Supplementary Material and Tables S1b, S1c and S2. The 408 
ophthalmological examinations included measurements of IOP and optic nerve head assessment. All 409 
19 studies contributed to the IOP mega/meta-analysis, 18 to the VCDR and 16 to the cup area and 410 
disc area mega/meta-analysis .Studies performed genomic imputation using 1000 Genomes phase 1 411 
reference samples . Study-specific quality control can be found in the Supplementary Material. All 412 
studies were performed with the approval of their local medical ethics committee, and written 413 
informed consent was obtained from all participants in accordance with the Declaration of Helsinki. 414 
 415 
Statistical analysis 416 
In the IOP analysis, individuals who underwent IOP-lowering laser or surgery were removed from the 417 
analysis; in individuals receiving IOP-lowering medication, the IOP value was multiplied by 1.3 to 418 
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estimate a pre-medication IOP value(66). The mean IOP, VCDR, cup area, and disc area of both eyes 419 
was used for the analyses. SNPs with MAF < 0.01 and imputation quality scores <0.3 (proper-info of 420 
IMPUTE) or R2<0.3 (MACH) were removed from the analyses. Each individual study performed a 421 
linear regression between each endophenotype (IOP, VCDR, cup area, and disc area) and the SNPs, 422 
under the assumption of an additive model for the effect of the risk allele. Analyses were adjusted 423 
for age, sex and the first five principal components (for population-based studies) or family structure 424 
(for family-based studies). 425 
We performed an inverse variance weighted fixed-effect meta-analysis with METAL software(67). P 426 
values for heterogeneity were calculated by using the Cochran’s Q-test for heterogeneity. SNPs with 427 
a p-value for heterogeneity <0.001 were removed from the results, as well as SNPs only present in 428 
three studies. We used the ‘genomic control’ option in METAL to correct the standard error of each 429 
individual study for estimated genomic inflation.(18) In the meta-analyses of individuals with 430 
European ancestry, a p-value <5.0 x 10-8 (the genome-wide threshold of association) was considered 431 
significant. In the second stage, these genome-wide significant SNPs were validated in individuals 432 
with Asian ancestry, and in this look-up a p value <0.05 was considered significant. Finally, in the 433 
meta-analysis of individuals with European and Asian ancestry a p-value of <5.0 x 10-8 was considered 434 
significant. In total, we identified 75 independent SNPs across different genomic regions for all the 435 
traits together. Therefore, the significance level after Bonferroni correction in the meta-analysis of 436 
POAG cohorts  was = 6.67 x 10-4 (0.05 / 75 independent SNPs). To estimate the common effect size of 437 
the top SNPs associated with IOP, optic disc parameters and their effect in the look-up in the POAG 438 
cohorts a random-effect meta-analysis was performed using plink(68) 439 
http://pngu.mgh.harvard.edu/purcell/plink/ parameter --meta-analysis. Manhattan, regional and 440 
forest plots were made using R(69) and LocusZoom(70). 441 
(18, 71) 442 
Gene-based test using VEGAS 443 
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A gene-based test was performed using the VEGAS2 software(72), with a 50kb gene boundary. We 444 
used the parameter ‘-top 100’ (default) to perform gene-based tests. This parameter considers 445 
association test statistics of all variants mapped to a gene to compute gene-based test statistics. The 446 
1000 Genomes European and Asian populations were used as a reference to calculate LD for 447 
European and Asian ancestry data respectively. After calculation of gene-based test statistics for 448 
Asian and European ancestry populations separately, meta-analyses were conducted using Fisher’s 449 
method for combining p-values. 450 
 451 
Functional characterization, expression data, zebrafish and gene-set enrichment 452 
We investigated for evidence of regulatory functions of associated loci HaploReg version 2(73) and 453 
Regulomedb version 1.1(74). We investigated the expression of the associated genes using NCBI’s 454 
UniGene(23) and The Ocular Tissue Database(24). We also investigated the expression of cdkn1a in a 455 
six6b knockdown zebrafish and used DEPICT to investigate gene-set enrichment. More information 456 
about these analyses can be found in the Supplementary Material. 457 
458 
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Legends to Figures 
Figure 1. Overlap between the genes associated with one or more endophenotypes. Genes 
with a genome-wide significant association for at least one trait are shown. These genes are 
counted as overlapping genes if they are Bonferroni significantly associated with the other 
trait(s). Chr 11p11.2 (see intraocular pressure circle) means a region on chromosome 
11p11.2 that is associated with IOP and has many genes in it; the likely causative gene in this 
region is not identified yet. Genes in bold are genes associated with primary open-angle 
glaucoma (POAG) in our meta-analysis of four case-control studies.*Genes associated with 
familial forms of POAG (e.g. MYOC and OPTN) or found in case-control association studies 
which did not show an association with the endophenotypes explored in this study.  
 
Figure 2. Pathways significantly enriched for: A) Loci associated with the vertical cup-disc ratio, 
cup area and intraocular pressure (p-value <7.0 x 10-6 in the GWAS). In total 11 meta-
pathways were identified after clustering the 57 pathways identified by DEPICT. B) Loci 
associated with vertical cup-disc ratio, cup area and disc area (p-value <1.0 x 10-5). In total 
17 meta-pathways were identified after clustering the 100 pathways identified by DEPICT. In 
both figures, meta-pathways are represented by nodes coloured according to statistical 
significance, and edges are scaled according to the correlation between meta-pathways. 
*The pathway “Abnormal eye morphology” clustered with the meta-pathway “Chordate 
embryonic development”. ELL2=Elongation Factor, RNA Polymerase II, DVL3= Dishevelled 
Segment Polarity Protein 3, THBS1=Thrombospondin 1, RFX2= Regulatory Factor X, 2. 
MDFI=MyoD Family Inhibitor.  
 
Figure 3. cdkn1a mRNA expression change 
Overexpression of cdkn1a and cdkn2a/cdkn2b in response to six6b depletion is shown. All 
samples expression were normalized to the control gene sdha. Relative expression was 
calculated by setting the wild-type expression level at 1. Values represent mean ± standard 
error of the mean. *P<0.05; **P<0.005. 
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Table 1. Single nucleotide polymorphisms (SNPs) that are genome-wide significantly associated with IOP and show and association with vertical cup-disc ratio.  
For these SNPs, the associations with the other traits are also included. SNPs that are Bonferroni significantly associated with other traits are shown in bold (p-value < 5.31 x 10-4; 
0.05/94). In the first rows, the SNPs genome-wide significantly associated with intraocular pressure (IOP) are shown. Next, the SNPs associated with IOP, vertical cup-disc ratio 
(VCDR), and cup area are shown. Nearest gene, reference NCBI build37; A1, reference allele; A2, other allele; β, effect size on the endophenotype (IOP, VCDR, cup area or disc area) 
based on allele A1; SE, standard error of the effect size; i, insertion; d, deletion; r, reference.  
   IOP VCDR Cup area Disc area 
SNP Nearest gene A1/A2 β SE P β SE P β SE P Β SE P 
rs10918274 TMCO1 t/c 0.26 0.04 5.64E-12 0.005 0.002 8.38E-03 0.010 0.003 2.47E-03 0.000 0.006 9.49E-01 
rs7635832 FNDC3B g/t -0.22 0.03 6.61E-13 -0.001 0.001 3.35E-01 -0.004 0.003 1.27E-01 0.002 0.005 7.08E-01 
rs10281637 CAV1/CAV2 c/t 0.20 0.03 3.96E-13 0.004 0.001 5.28E-03 0.006 0.003 1.23E-02 -0.002 0.005 6.01E-01 
8:78380944 PKIA i/r 1.00 0.17 7.54E-09 0.000 0.010 9.74E-01 -0.018 0.017 3.00E-01 0.018 0.031 5.61E-01 
rs7815043 PKIA c/t -0.10 0.03 4.41E-05 -0.001 0.001 3.13E-01 -0.001 0.002 8.32E-01 -0.002 0.004 5.66E-01 
rs7944735 Many genes c/g 0.19 0.03 6.00E-11 0.001 0.001 4.37E-01 0.006 0.003 3.33E-02 0.000 0.005 9.68E-01 
11:120357425 ARHGEF12 d/r 0.18 0.03 2.02E-09 0.001 0.001 6.12E-01 0.001 0.003 6.45E-01 0.001 0.005 8.38E-01 
rs12794618 ARHGEF12 c/t 0.17 0.03 7.86E-09 0.001 0.001 4.14E-01 0.002 0.003 4.84E-01 0.004 0.005 4.53E-01 
rs55796939 ADAMTS8 t/c 0.36 0.06 2.31E-08 0.003 0.003 3.61E-01 0.006 0.006 3.19E-01 -0.003 0.010 7.95E-01 
               
rs2472496 ABCA1 g/a 0.17 0.02 1.93E-13 0.004 0.001 6.83E-05 0.010 0.002 9.63E-07 0.003 0.004 4.75E-01 
rs8176741 ABO a/g 0.24 0.04 3.47E-10 0.007 0.002 4.51E-05 0.019 0.003 7.12E-08 0.004 0.006 5.42E-01 
rs9913911 GAS7 g/a -0.17 0.02 7.01E-12 -0.006 0.001 1.84E-07 -0.008 0.002 2.48E-04 -0.001 0.004 8.41E-01 
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Table 2a. Single nucleotide polymorphisms (SNPs) that are genome-wide significantly associated with vertical cup-disc ratio and show an association with cup area and disc area 
   IOP VCDR   Cup area Disc area 
SNP Nearest 
gene 
A1/A2 β SE P β SE P β SE P Β SE P 
rs6804624 COL8A1 c/t -0.01 0.03 6.54E-01 0.008 0.001 8.63E-12 0.013 0.002 1.99E-08 0.020 0.004 9.67E-07 
rs7916697 ATOH7 a/g 0.01 0.03 7.43E-01 -0.018 0.001 2.46E-45 -0.017 0.002 1.32E-12 -0.094 0.004 1.34E-102 
10:96008348 PLCE1 d/r 0.01 0.03 5.73E-01 0.007 0.001 4.57E-08 0.013 0.002 1.72E-08 0.015 0.004 2.22E-04 
rs324780 TMTC2 g/a 0.03 0.02 2.79E-01 -0.011 0.001 7.16E-23 -0.016 0.002 1.57E-13 -0.029 0.004 8.58E-13 
rs4299136 ASB7 c/g -0.03 0.03 4.22E-01 0.010 0.002 2.68E-12 0.018 0.003 4.09E-10 0.024 0.005 4.02E-06 
16:51461915 SALL1 r/i 0.02 0.03 4.34E-01 0.010 0.001 2.62E-13 0.013 0.003 6.78E-07 0.032 0.005 2.38E-12 
rs4784295 SALL1 c/g 0.02 0.03 5.63E-01 0.009 0.001 3.93E-13 0.013 0.003 1.63E-07 0.031 0.005 1.12E-11 
rs5752773 CHEK2 g/c 0.01 0.03 6.91E-01 -0.012 0.001 1.49E-20 -0.024 0.003 4.12E-21 -0.024 0.005 1.48E-07 
rs2092172 CARD10 a/g 0.00 0.03 8.86E-01 0.009 0.001 3.08E-12 0.011 0.003 3.34E-05 0.032 0.005 1.44E-11 
rs7717697 VCAN c/t 0.01 0.02 7.21E-01 -0.007 0.001 6.66E-09 -0.009 0.002 1.19E-05 -0.018 0.004 4.84E-06 
rs1681739 ENO4 t/c 0.03 0.02 2.23E-01 0.006 0.001 2.44E-08 0.011 0.002 3.70E-07 0.019 0.004 1.85E-06 
rs60779155 ASB7 a/g -0.02 0.04 6.61E-01 0.010 0.002 3.76E-10 0.019 0.003 3.75E-09 0.030 0.006 8.26E-08 
rs1830890 PLCE1 g/a 0.01 0.02 8.14E-01 0.006 0.001 3.02E-08 0.012 0.002 1.06E-07 0.013 0.004 5.51E-04 
rs482507 TMTC2 c/t 0.02 0.02 3.48E-01 -0.011 0.001 2.19E-19 -0.017 0.002 2.56E-14 -0.030 0.004 4.49E-13 
rs4436712 SIX6 t/g -0.04 0.02 1.47E-01 0.009 0.001 5.48E-14 0.025 0.002 1.50E-29 -0.018 0.004 6.59E-06 
rs738722 CHEK2 t/c 0.02 0.03 3.57E-01 -0.012 0.001 4.94E-20 -0.024 0.003 7.81E-22 -0.021 0.005 2.63E-06 
rs2684249 HSF2 c/t 0.03 0.02 2.08E-01 -0.006 0.001 1.64E-07 -0.012 0.002 3.04E-08 -0.015 0.004 1.49E-04 
rs34222435 ASB7 t/c -0.03 0.03 3.86E-01 0.010 0.002 3.07E-12 0.019 0.003 1.07E-10 0.025 0.005 2.98E-06 
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   IOP VCDR Cup area Disc area 
SNP Nearest 
gene 
A1/A2 β SE P β SE P β SE P Β SE P 
rs7916410 ATOH7 t/c 0.00 0.03 9.76E-01 -0.018 0.001 1.14E-45 -0.017 0.002 6.11E-12 -0.097 0.004 7.06E-109 
rs442376 TMTC2 c/t -0.03 0.03 3.09E-01 0.011 0.001 1.50E-17 0.017 0.002 3.18E-12 0.032 0.004 4.92E-14 
rs1345467 SALL1 g/a 0.01 0.03 6.53E-01 0.009 0.001 4.96E-12 0.012 0.003 1.07E-06 0.032 0.005 6.41E-13 
rs5762752 CHEK2 c/g 0.01 0.03 6.61E-01 -0.011 0.001 4.83E-18 -0.021 0.002 6.72E-19 -0.023 0.004 2.26E-08 
rs11129176 RARB a/g 0.02 0.03 4.17E-01 0.005 0.001 3.17E-05 0.010 0.002 1.01E-05 0.023 0.004 3.40E-08 
rs1997404 COL8A1 g/t -0.03 0.03 3.24E-01 0.008 0.001 2.39E-11 0.013 0.002 7.71E-08 0.024 0.004 1.90E-08 
rs34935520 SIX6 g/a -0.04 0.02 1.13E-01 0.009 0.001 7.95E-14 0.025 0.002 6.96E-29 -0.023 0.004 7.61E-08 
For these SNPs, the associations with the other traits are also included. Here the SNPs genome-wide significantly associated with vertical cup-disc ratio that are Bonferroni 
significantly associated with cup area or disc area are shown in bold (p-value < 5.31 x 10-4; 0.05/94).Nearest gene, reference NCBI build37; A1, reference allele; A2, other allele; β, 
effect size on the effect size on the endophenotype (IOP, VCDR, cup area or disc area) based on allele A1; SE, standard error of the effect size; i, insertion; d, deletion; r, reference. 
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Table2b. Single nucleotide polymorphisms (SNPs) that are genome-wide significantly associated with vertical cup-disc ratio and show an association with cup area  
   IOP VCDR Cup area Disc area 
SNP Nearest gene A1/A
2 
β SE P β SE P β SE P Β SE P 
rs1925953 RPE65 t/a -0.02 0.02 3.26E-01 0.006 0.001 1.55E-07 0.010 0.002 1.50E-05 0.006 0.004 1.08E-01 
rs72759609 PDZD2 c/t -0.04 0.05 3.50E-01 -0.012 0.002 7.10E-09 -0.020 0.004 1.98E-06 -0.021 0.008 5.62E-03 
rs11450334
6 
DUSP1 t/c -0.12 0.08 1.27E-01 -0.021 0.004 1.31E-08 -0.035 0.007 2.90E-07 -0.035 0.013 5.83E-03 
rs4960295 RREB1 a/g 0.02 0.02 4.75E-01 0.007 0.001 2.49E-10 0.009 0.002 3.73E-05 0.012 0.004 3.29E-03 
rs10274998 DGKB t/c 0.02 0.03 4.38E-01 0.008 0.001 4.68E-08 0.012 0.003 8.08E-06 0.011 0.005 2.65E-02 
rs2157719 CDKN2B-AS1 c/t -0.04 0.02 9.81E-02 -0.013 0.001 3.75E-35 -0.024 0.002 3.31E-28 -0.008 0.004 3.03E-02 
rs3891783 PLCE1 g/c 0.04 0.02 1.01E-01 0.007 0.001 1.06E-10 0.011 0.002 3.28E-07 0.012 0.004 1.52E-03 
rs1346 SSSCA1 t/a -0.05 0.03 1.20E-01 -0.013 0.002 7.51E-18 -0.019 0.003 9.31E-11 -0.016 0.005 2.10E-03 
rs4936099 ADAMTS8 c/a -0.03 0.03 2.38E-01 -0.007 0.001 6.70E-09 -0.013 0.002 4.96E-08 -0.006 0.004 1.72E-01 
13:3662990
5 
DCLK1 d/r -0.02 0.03 5.70E-01 0.007 0.001 2.98E-08 0.018 0.002 2.20E-14 -0.005 0.004 2.36E-01 
rs7323428 DCLK1 t/g -0.02 0.03 4.13E-01 0.007 0.001 1.86E-08 0.019 0.002 1.67E-15 -0.005 0.004 2.23E-01 
rs8015152 SIX6 t/c -0.06 0.02 2.27E-02 0.010 0.001 2.86E-18 0.024 0.002 8.15E-26 -0.011 0.004 6.18E-03 
rs6107845 BMP2 a/g 0.03 0.02 2.80E-01 -0.009 0.001 3.44E-17 -0.017 0.002 2.90E-15 -0.004 0.004 3.27E-01 
rs6764184 FLNB t/g 0.05 0.03 5.03E-02 0.007 0.001 1.89E-08 0.015 0.002 1.30E-10 0.010 0.004 1.92E-02 
rs7311936 FAM101A c/g -0.03 0.02 1.69E-01 -0.006 0.001 2.48E-09 -0.013 0.002 4.52E-09 0.003 0.004 5.14E-01 
14:2338879
3 
RBM23 r/d 0.02 0.03 3.99E-01 0.007 0.001 2.56E-08 0.013 0.003 2.01E-07 0.009 0.005 4.29E-02 
rs3794453 RBM23 a/t 0.01 0.02 7.22E-01 0.007 0.001 7.25E-08 0.011 0.002 2.88E-07 0.009 0.004 3.11E-02 
rs2252865 RERE t/c 0.05 0.03 4.11E-02 0.005 0.001 2.66E-05 0.014 0.002 1.33E-09 0.003 0.004 5.08E-01 
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   IOP VCDR Cup area Disc area 
SNP Nearest gene A1/A
2 
β SE P β SE P β SE P Β SE P 
rs4846112 DHRS3 a/g -0.02 0.03 5.12E-01 -0.005 0.001 2.39E-04 -0.012 0.002 2.38E-07 0.005 0.004 2.25E-01 
rs13016883 TRIB2 c/g 0.01 0.03 5.64E-01 0.006 0.001 3.44E-06 0.016 0.002 1.83E-11 0.001 0.004 8.30E-01 
rs35084382 DUSP1 c/t -0.10 0.07 1.32E-01 -0.018 0.003 2.05E-08 -0.033 0.006 2.17E-08 -0.031 0.011 5.51E-03 
rs11759831
0 
CRISPLD1 t/g -0.05 0.05 3.10E-01 0.009 0.002 1.07E-04 0.021 0.004 1.66E-06 0.022 0.008 5.47E-03 
rs1360589 CDKN2B-AS1 c/t -0.04 0.02 8.42E-02 -0.013 0.001 1.43E-34 -0.024 0.002 2.90E-28 -0.008 0.004 4.45E-02 
rs11613189 FAM101A t/c -0.03 0.03 2.27E-01 -0.005 0.001 6.04E-06 -0.016 0.002 2.01E-12 0.002 0.004 6.42E-01 
rs2251069 DDHD1 c/t 0.01 0.02 7.29E-01 -0.006 0.001 7.41E-08 -0.013 0.002 1.20E-09 0.001 0.004 7.11E-01 
rs6598351 FAM169B t/c -0.02 0.03 5.26E-01 0.006 0.001 2.80E-05 0.012 0.003 1.77E-05 -0.004 0.005 3.90E-01 
rs11646917 SALL1 t/g -0.01 0.03 6.65E-01 -0.009 0.001 4.83E-10 -0.015 0.003 4.76E-09 -0.015 0.005 1.30E-03 
rs11867840 BCAS3 g/a 0.04 0.03 1.04E-01 -0.006 0.001 4.86E-06 -0.018 0.002 2.35E-13 0.011 0.004 1.00E-02 
rs6054375 BMP2 t/g 0.03 0.03 2.45E-01 -0.010 0.001 6.92E-15 -0.018 0.002 1.83E-15 -0.003 0.004 4.74E-01 
rs3791679 EFEMP1/PNPT
1 
g/a 0.04 0.03 1.72E-01 -0.005 0.001 1.17E-04 -0.013 0.002 4.92E-08 0.003 0.004 5.14E-01 
rs12494328 FLNB a/g 0.04 0.03 1.52E-01 0.006 0.001 1.56E-06 0.016 0.002 6.03E-11 0.009 0.004 4.50E-02 
6:36592986 CDKN1A d/r -0.02 0.03 5.32E-01 0.006 0.001 1.92E-05 0.015 0.003 1.12E-08 -0.006 0.005 2.09E-01 
rs72852338 CDKN1A c/a -0.02 0.03 5.46E-01 0.006 0.001 3.29E-05 0.014 0.003 3.17E-08 -0.005 0.005 2.97E-01 
rs1074407 TRIOBP t/a 0.11 0.02 4.00E-06 0.006 0.001 3.32E-07 0.012 0.002 1.90E-08 0.008 0.004 3.92E-02 
For these SNPs, the associations with the other traits are also included. Here the SNPs genome-wide significantly associated with vertical cup-disc ratio that are Bonferroni 
significantly associated with cup area are shown in bold (p-value < 5.31 x 10-4; 0.05/94).Nearest gene, reference NCBI build37; A1, reference allele; A2, other allele; β, effect size on 
effect size on the endophenotype (IOP, VCDR, cup area or disc area) based on allele A1; SE, standard error of the effect size; i, insertion; d, deletion; r, reference. 
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Table2c. Single nucleotide polymorphisms (SNPs) that are genome-wide significantly associated with vertical cup-disc ratio and show an association with disc area 
   IOP VCDR Cup area Disc area 
SNP Nearest gene A1/A
2 
β SE P β SE P β SE P Β SE P 
rs1192414 CDC7/TGFBR
3 
a/g 0.06 0.03 5.66E-02 0.014 0.001 1.78E-23 0.007 0.003 1.12E-02 0.087 0.005 7.44E-71 
rs10753787 F5 t/c -0.03 0.02 1.69E-01 -0.007 0.001 2.48E-09 -0.005 0.002 2.14E-02 -0.019 0.004 1.60E-06 
rs2920293 PSCA g/c 0.00 0.02 8.57E-01 -0.006 0.001 5.04E-09 -0.007 0.002 9.17E-04 -0.015 0.004 9.94E-05 
rs4658101 CDC7/TGFBR
3 
a/g 0.06 0.03 4.46E-02 0.013 0.001 5.19E-23 0.007 0.003 1.13E-02 0.089 0.005 8.01E-77 
1:16953052
0 
F5/SELP i/r 0.02 0.03 4.22E-01 0.007 0.001 7.20E-07 0.005 0.003 5.44E-02 0.033 0.005 1.49E-12 
rs2239854 F5/SELP a/g 0.03 0.03 2.64E-01 0.006 0.001 8.37E-07 0.005 0.002 5.04E-02 0.030 0.004 7.60E-13 
rs9843102 ABI3BP a/g 0.00 0.03 9.84E-01 -0.006 0.002 2.18E-04 -0.002 0.003 5.88E-01 -0.036 0.005 1.35E-11 
8:88744441 DCAF4L2 d/r -0.01 0.02 6.98E-01 0.006 0.001 6.66E-07 0.006 0.002 4.53E-03 0.026 0.004 2.04E-11 
rs6468996 DCAF4L2 t/c 0.00 0.02 9.12E-01 0.005 0.001 2.52E-07 0.006 0.002 2.14E-03 0.025 0.004 5.16E-11 
rs61101201 ELP4/PAX6 g/t 0.02 0.03 5.51E-01 0.006 0.001 2.27E-06 0.005 0.002 4.51E-02 0.028 0.004 1.53E-10 
rs56385951 CARD10 a/g -0.06 0.04 9.08E-02 0.011 0.002 1.87E-11 0.008 0.003 8.83E-03 0.047 0.006 1.49E-16 
1:3046430 PRDM16 i/r -0.04 0.04 4.14E-01 0.007 0.002 5.35E-04 -0.002 0.004 7.15E-01 0.044 0.007 1.79E-09 
rs12028027 PRDM16 c/t -0.03 0.04 4.97E-01 0.007 0.002 2.15E-04 -0.001 0.004 8.58E-01 0.043 0.007 1.46E-09 
For these SNPs, the associations with the other traits are also included. Here the SNPs genome-wide significantly associated with vertical cup-disc ratio that are Bonferroni 
significantly associated with disc area are shown in bold (p-value < 5.31 x 10-4; 0.05/94).Nearest gene, reference NCBI build37; β, effect size on effect size on the endophenotype 
(IOP, VCDR, cup area or disc area) based on allele A1; SE, standard error of the effect size; i, insertion; d, deletion; r, reference. 
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Table 3 Single nucleotide polymorphisms (SNPs) that are genome-wide significantly associated with optic nerve head parameters (cup area and disc area) 
   IOP VCDR Cup area Disc area 
SNP Nearest gene A1/A2 β SE P β SE P β SE P Β SE P 
1:227562773 CDC42BPA d/r -0.10 0.05 3.01E-02 0.003 0.002 2.37E-01 0.024 0.004 8.05E-09 -0.055 0.008 3.65E-13 
rs73102394 CDC42BPA t/c -0.09 0.05 4.34E-02 0.003 0.002 1.62E-01 0.022 0.004 4.16E-08 -0.053 0.007 5.01E-13 
rs11811982 CDC42BPA a/c -0.12 0.05 1.35E-02 0.004 0.002 5.54E-02 0.027 0.004 2.31E-10 -0.062 0.008 2.02E-15 
               
rs10021731 UGT8 c/t 0.01 0.02 8.23E-01 -0.002 0.001 5.56E-02 -0.002 0.002 2.68E-01 -0.020 0.004 7.48E-07 
rs12220165 CTNNA3 g/c 0.02 0.03 5.88E-01 -0.004 0.002 1.47E-02 -0.004 0.003 1.92E-01 -0.023 0.005 2.51E-05 
rs787541 U6, GADD45A c/g 0.07 0.03 7.08E-03 0.002 0.001 7.47E-02 0.002 0.002 4.82E-01 0.023 0.004 6.66E-08 
rs1367187 DIRC3 c/t -0.07 0.03 9.74E-03 0.002 0.001 2.46E-01 -0.002 0.003 4.87E-01 0.026 0.005 1.03E-08 
rs2443724 VGLL4 c/g 0.00 0.02 8.62E-01 -0.003 0.001 1.53E-02 0.000 0.002 9.15E-01 -0.022 0.004 4.72E-08 
rs1013830 CTNNA3 t/c 0.00 0.05 9.49E-01 -0.007 0.002 4.80E-03 -0.004 0.005 4.10E-01 -0.046 0.008 5.45E-08 
 
For these SNPs, the associations with the other traits are also included. SNPs that are Bonferroni significantly associated with other traits are shown in bold (p-value < 5.31 x 10-4; 
0.05/94). In the first rows, the SNPs genome-wide significantly associated with cup area are shown. Next, SNPs associated with only disc area, are shown. Nearest gene, reference 
NCBI build37; A1, reference allele; A2, other allele; β, effect size on the endophenotype (IOP, VCDR, cup area or disc area) based on allele A1; SE, standard error of the effect size; i, 
insertion; d, deletion; r, reference. 
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Table 4. Association with primary open-angle glaucoma in a meta-analysis of four independent glaucoma case-
control studies (ANZRAG, NEIGHBORHOOD, Singapore, and Southampton).  
 Nearest gene A1/A2 OR OR 
(R) 
P-value P-value 
(R) 
Direction I2 P-value of 
heterogeneity 
IOP SNPs 
rs10918274 TMCO1 t/c 1.39 1.39 2.75E-19 1.37E-09 ++++ 38.4 1.82E-01 
rs7635832 
FNDC3B 
g/t 
0.89 
0.91 
1.41E-03 
3.65E-02 
---? 
33.9 
2.20E-01 
rs10281637 CAV1/CAV2 c/t 1.13 1.13 2.32E-05 2.32E-05 ++++ 0 4.89E-01 
rs2487048 ABCA1 a/g 1.26 1.26 2.65E-15 3.82E-03 ++++ 82.9 5.53E-04 
rs8176741 ABO a/g 1.07 1.04 7.36E-02 5.25E-01 -+-+ 58.5 6.51E-02 
rs7944735 Many genes 
(NUP160, PTPRJ) 
c/g 1.06 1.07 2.99E-02 2.99E-02 ++++ 0 8.99E-01 
11:120357425 ARHGEF12 d/r 1.16 1.19 1.52E-06 3.02E-02 ++++ 83.2 4.65E-04 
rs55796939 ADAMTS8 t/c 1.07 1.17 2.72E-01 4.46E-01 +?-- 78.6 9.35E-03 
rs9913911 GAS7 g/a 0.80 0.80 1.08E-17 1.08E-17 ---- 0 7.50E-01 
 
VCDR SNPs 
rs1925953 RPE65 t/a  1.07 1.10 4.21E-03 2.01E-02 ++++ 46.7 1.31E-01 
rs1192414 CDC7/TGFBR3 a/g 1.08 1.08 9.26E-03 9.26E-03 ++++ 0 7.27E-01 
rs10753787 F5 t/c 0.97 0.97 3.67E-01 3.67E-01 ---- 0 9.92E-01 
rs6804624 COL8A1 c/t 0.99 0.99 8.14E-01 8.14E-01 ---+ 0 8.42E-01 
rs72759609 PDZD2 c/t 0.90 0.91 3.20E-02 3.20E-02 ---- 0 9.53E-01 
rs114503346 DUSP1 t/c 1.00 1.00 9.99E-01 8.80E-01 +?-+ 42 1.78E-01 
rs4960295 RREB1 a/g 0.99 1.00 9.50E-01 9.09E-01 -+-+ 4.6 3.70E-01 
rs10274998 DGKB t/c 1.03 1.04 2.16E-01 2.16E-01 ++-+ 0 5.38E-01 
rs2157719 CDKN2B-AS1 c/t 0.69 0.69 1.29E-40 1.29E-40 ---- 0 5.67E-01 
rs1900005 ATOH7 a/c 1.01 1.01 6.98E-01 6.77E-01 +-++ 5.1 3.67E-01 
10:96008348 PLCE1 d/r 1.02 1.04 3.38E-01 3.15E-01 +-+? 35.3 2.13E-01 
rs1346 SSSCA1 t/a 0.90 0.91 2.41E-03 2.41E-03 ---- 0 9.04E-01 
rs4936099 ADAMTS8 c/a 0.94 0.94 5.75E-02 5.75E-02 ---- 0 9.63E-01 
rs324780 TMTC2 g/a 0.93 0.93 1.35E-02 1.35E-02 ---- 0 7.69E-01 
13:36629905 DCLK1 d/r 0.99 0.99 7.53E-01 8.00E-01 --+- 6.2 3.62E-01 
rs8015152 SIX6 t/c 1.21 1.19 3.90E-15 7.08E-05 ++++ 62.4 4.62E-02 
rs4299136 ASB7 c/g 1.03 1.03 3.55E-01 3.55E-01 ++-+ 0 8.29E-01 
16:51461915 SALL1 i/r 0.94 0.94 3.85E-02 3.85E-02 ---- 0 7.82E-01 
rs6107845 BMP2 a/g 0.89 0.91 1.02E-05 6.94E-03 ---- 43.1 1.53E-01 
rs5752773 CHEK2 g/c 0.92 0.92 4.63E-03 4.63E-03 ---- 0 9.12E-01 
rs2092172 CARD10 a/g 0.97 0.98 4.35E-01 4.35E-01 --+- 0 7.76E-01 
rs6764184 FLNB t/g 1.07 1.02 5.73E-03 7.66E-01 ++-+ 86.1 8.14E-05 
rs7717697 VCAN c/t 0.98 0.98 5.26E-01 5.26E-01 ---? 0 7.30E-01 
rs2920293 PSCA g/c 1.03 1.03 2.25E-01 2.25E-01  ++-? 0 3.79E-01 
rs1681739 ENO4 t/c 1.02 1.03 3.92E-01 3.99E-01 +--+ 49.2 1.16E-01 
rs7311936 FAM101A c/g 0.99 1.00 8.12E-01 8.59E-01 +--- 11 3.38E-01 
14:23388793 RBM23 r/d 1.03 1.03 1.83E-01 1.83E-01 +++? 0 4.61E-01 
 
Cup area  SNPs 
rs2252865 RERE t/c 1.11 1.11 5.76E-05 2.87E-02 ++-+ 59.3 6.10E-02 
rs4846112 DHRS3 a/g 0.95 0.96 1.18E-01 1.18E-01 ---- 0 5.53E-01 
1:227562773 CDC42BPA d/r 0.87 0.90 1.14E-02 2.11E-01 --+? 48.6 1.43E-01 
rs13016883 TRIB2 c/g 1.08 1.08 4.25E-03 4.25E-03 +++? 0 8.63E-01 
rs35084382 DUSP1 c/t 1.04 1.05 6.72E-01 6.72E-01  +?-+ 0 3.91E-01 
rs117598310 CRISPLD1 t/g 1.08 1.09 5.39E-02 5.39E-02 +++ 0 8.01E-01 
rs1360589 CDKN2B-AS1 c/t 0.69 0.69 1.90E-42 1.90E-42 ---- 0 6.47E-01 
rs10998036 ATOH7 c/g 1.01 1.02 5.42E-01 5.72E-01 +--- 26 2.55E-01 
10:96008348 PLCE1 d/r 1.02 1.04 3.38E-01 3.15E-01 +-+? 35.3 2.13E-01 
rs1346 SSSCA1 t/a  0.90 0.91 2.41E-03 2.41E-03 ---- 0 9.04E-01 
rs482507 TMTC2 c/t 0.94 0.94 2.03E-02 2.03E-02 ---- 0 7.46E-01 
rs11613189 FAM101A t/c 0.99 0.99 8.25E-01 7.77E-01 ++-- 18.5 2.98E-01 
rs7323428 DCLK1 t/g 0.99 1.00 7.83E-01 8.87E-01 +-+- 13.6 3.25E-01 
rs2251069 DDHD1 c/t 0.95 0.96 7.62E-02 7.62E-02  --+- 0 4.08E-01 
rs4436712 SIX6 t/g 1.24 1.23 
 
 
 
5.77E-18 1.52E-07 ++++ 48.8 1.19E-01 
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 Nearest gene A1/A2 OR OR 
(R) 
P-value P-value 
(R) 
Direction I2 P-value of 
heterogeneity 
Cup area  SNPs 
rs6598351 FAM169B t/c 0.99 0.99 8.06E-01 8.06E-
01 
-+-- 0 7.11E-01 
rs11646917 SALL1 t/3g 0.98 0.98 5.49E-01 5.49E-
01 
--++ 0 5.97E-01 
rs11867840 BCAS3 g/a 1.06 1.06 1.83E-02 2.12E-
02 
++++ 8.3 3.51E-01 
rs6054375 BMP2 t/g 0.89 0.91 8.52E-06 9.93E-
03 
---- 47.1 1.29E-01 
rs738722 CHEK2 t/c 0.93 0.93 1.26E-02 1.26E-
02 
---- 0 9.05E-01 
rs3791679 EFEMP1/PNPT1 a/g 0.96 0.96 2.23E-01 2.23E-
01 
---- 0 5.51E-01 
rs12494328 FLNB a/g 1.13 1.13 1.28E-05 5.89E-
04 
++-+ 26.9 2.50E-01 
rs6804624 COL8A1 c/t 0.99 0.99 8.14E-01 8.14E-
01 
---+ 0 8.42E-01 
6:36592986 CDKN1A d/r 1.14 1.15 7.74E-07 1.04E-
04 
++++ 36.6 1.93E-01 
rs2684249 HSF2 c/t 0.92 0.94 1.08E-03 1.66E-
01 
---+ 63.3 4.25E-02 
rs8176672 ABO t/c 1.00 1.00 9.49E-01 9.49E-
01 
-+-? 0 3.69E-01 
rs4936099 ADAMTS8 c/a 0.94 0.94 5.75E-02 5.75E-
02 
---- 0 9.63E-01 
rs34222435 ASB7 t/c 1.03 1.03 3.66E-01 3.66E-
01 
++-+ 0 8.74E-01 
rs1074407 TRIOBP t/a 1.04 1.04 4.92E-02 8.66E-
02 
++++ 32.9 2.15E-01 
  
Disc Area SNPs 
rs4658101 CDC7/TGFBR3 a/g 1.08 1.08 7.81E-03 7.81E-03 ++++ 0 7.22E-01 
1:169530520 F5/SELP i/r 1.01 1.02 5.40E-01 5.40E-01 ++-? 0 7.14E-01 
rs11811982 CDC42BPA a/c 0.87 0.90 1.19E-02 8.28E-02 --++ 20.5 2.87E-01 
rs9843102 ABI3BP a/g 0.92 0.92 1.37E-02 1.37E-02 ---- 0 6.24E-01 
rs10021731 UGT8 c/t 1.01 1.01 6.82E-01 6.82E-01  --++ 0 6.50E-01 
8:88744441 DCAF4L2 d/r 1.03 1.04 0.1225 1.39E-01 ++-+ 4.9 3.68E-01 
rs12220165 CTNNA3 g/c 1.08 1.09 1.14E-02 1.14E-02 ++++ 0 9.04E-01 
rs7916410 ATOH7 t/c 1.00 1.00 7.63E-01 7.45E-01 +-++ 3.9 3.73E-01 
rs61101201 ELP4/PAX6 g/t 1.00 1.00 9.77E-01 9.77E-01  -+-? 0 9.63E-01 
rs442376 TMTC2 c/t 1.04 1.05 7.94E-02 7.94E-02  -+++ 0 6.82E-01 
rs1345467 SALL1 g/a  1.07 1.07 1.86E-02 1.86E-02 ++++ 0 8.73E-01 
rs5762752 CHEK2 c/g 0.92 0.92 4.90E-03 4.90E-03 ---- 0 8.29E-01 
rs56385951 CARD10 a/g 0.99 1.00 9.15E-01 9.15E-01 +-+- 0 9.88E-01 
1:3046430 PRDM16 i/r 0.97 0.98 7.13E-01 8.72E-01 +--? 63.9 6.28E-02 
rs787541 U6, GADD45A c/g 0.98 0.98 6.10E-01 9.06E-01 --++ 50.7 1.08E-01 
rs1367187 DIRC3 c/t 0.95 0.96 1.11E-01 4.12E-01  +-+- 46.1 1.35E-01 
rs2443724 VGLL4 c/g 0.91 0.91 1.04E-03 2.61E-02 --+- 38 1.84E-01 
rs11129176 RARB a/g 0.99 1.00 8.85E-01 9.93E-01 +--- 40.4 1.69E-01 
rs1997404 COL8A1 g/t 1.00 1.00 9.60E-01 9.60E-01  -+++ 0 6.18E-01 
rs34935520 SIX6 g/a 1.26 1.26 2.82E-20 6.73E-14 ++++ 21.5 2.81E-01 
rs60779155 ASB7 a/g 1.02 1.03 4.52E-01 4.52E-01 +--+ 0 5.02E-01 
Results are shown for the most significantly associated single nucleotide polymorphisms from the endophenotype analyses. 
Nearest gene, reference NCBI build37; A1, reference allele; A2, other allele; OR, estimated odds ratio for allele A1; OR (R), 
estimated odds ratio for allele A1 in random effect meta-analysis; 95% CI, confidence interval; P-value (R), p-value in 
random effect meta-analysis; I2 statistic measuring heterogeneity on a scale of 0% to 100%; i, insertion; d, deletion; r, 
reference. 
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Abbreviations 
Abbreviation Explanation 
A1 Reference allele  
A2 Other allele 
Chr Chromosome 
CI  confidence interval 
d Deletion  
FDR False Discovery Rate 
GWAS Genome-wide association studies  
h2 Heritability 
i Insertion  
I2  Statistic measuring heterogeneity on a scale of 0% to 100% 
IGGC International Glaucoma Genetics Consortium 
IOP Intraocular pressure  
LCA2 Leber Congenital Amaurosis type 2  
LD Linkage disequilibrium 
MAF Minor allele frequency  
OR Estimated odds ratio for allele A1  
OR (R) Estimated odds ratio for allele A1 in random effect meta-analysis 
POAG Primary open-angle glaucoma 
r  Reference 
RP Retinitis Pigmentosa 
SE  Standard error 
SNPs Single nucleotide polymorphisms  
VCDR Vertical cup-disc ratio  
β  Effect size  
 
